Top Qs
Timeline
Chat
Perspective

Noradrenergic and specific serotonergic antidepressant

Class of antidepressants From Wikipedia, the free encyclopedia

Noradrenergic and specific serotonergic antidepressant
Remove ads
Remove ads

Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of psychiatric drugs used primarily as antidepressants.[1] They act by antagonizing the α2-adrenergic receptor and certain serotonin receptors such as 5-HT2A and 5-HT2C,[1] but also 5-HT3,[1] 5-HT6, and/or 5-HT7 in some cases. By blocking α2-adrenergic autoreceptors and heteroreceptors, NaSSAs enhance adrenergic and serotonergic neurotransmission in the brain involved in mood regulation,[1] notably 5-HT1A-mediated transmission.[2] In addition, due to their blockade of certain serotonin receptors, serotonergic neurotransmission is not facilitated in unwanted areas, which prevents the incidence of many side effects often associated with selective serotonin reuptake inhibitor (SSRI) antidepressants;[1][3] hence, in part, the "specific serotonergic" label of NaSSAs.[2]

Thumb
Chemical structure of the prototypical NaSSA mirtazapine (original brand name Remeron)
Remove ads

List of NaSSAs

The NaSSAs include the following agents:

Notably, all of these compounds are analogues and are also classified as tetracyclic antidepressants (TeCAs) based on their chemical structures.

S32212, a structurally novel NaSSA with an improved selectivity profile (e.g., no antihistamine effects, etc.), was reported in 2012.[5][6] It has completed preliminary preclinical research and may go on to undergo clinical trials.

Remove ads

See also

References

Further reading

Loading content...
Loading content...
Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads